PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 550.0
(0.92%)
IDR 550.0
(0.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 827.82 Billion IDR | 2.91% |
| 2022 | 787.85 Billion IDR | 8.58% |
| 2021 | 725.59 Billion IDR | 4.7% |
| 2020 | 692.98 Billion IDR | 4.53% |
| 2019 | 662.95 Billion IDR | 7.5% |
| 2018 | 616.69 Billion IDR | 15.86% |
| 2017 | 532.26 Billion IDR | 7.38% |
| 2016 | 495.69 Billion IDR | 22.53% |
| 2015 | 404.54 Billion IDR | 0.93% |
| 2014 | 400.79 Billion IDR | -18.89% |
| 2013 | 494.12 Billion IDR | 18.69% |
| 2012 | 416.32 Billion IDR | -5.11% |
| 2011 | 438.74 Billion IDR | 24.98% |
| 2010 | 351.05 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 166.95 Billion IDR | -24.86% |
| 2024 Q1 | 130.65 Billion IDR | -53.42% |
| 2024 Q2 | 215.47 Billion IDR | 64.92% |
| 2023 FY | 810.75 Billion IDR | 2.91% |
| 2023 Q1 | 120.88 Billion IDR | -56.22% |
| 2023 Q2 | 184.25 Billion IDR | 52.42% |
| 2023 Q4 | 280.49 Billion IDR | 24.59% |
| 2023 Q3 | 225.12 Billion IDR | 22.18% |
| 2022 Q3 | 196.67 Billion IDR | 4.86% |
| 2022 Q1 | 127.5 Billion IDR | -43.5% |
| 2022 FY | 787.85 Billion IDR | 8.58% |
| 2022 Q4 | 276.12 Billion IDR | 40.4% |
| 2022 Q2 | 187.55 Billion IDR | 47.1% |
| 2021 Q4 | 225.67 Billion IDR | 27.26% |
| 2021 Q1 | 129.45 Billion IDR | -48.9% |
| 2021 Q2 | 193.12 Billion IDR | 49.18% |
| 2021 Q3 | 177.33 Billion IDR | -8.18% |
| 2021 FY | 725.59 Billion IDR | 4.7% |
| 2020 Q1 | 128.58 Billion IDR | -42.63% |
| 2020 Q3 | 160.86 Billion IDR | 7.1% |
| 2020 Q2 | 150.19 Billion IDR | 16.81% |
| 2020 FY | 692.98 Billion IDR | 4.53% |
| 2020 Q4 | 253.33 Billion IDR | 57.49% |
| 2019 Q1 | 121.24 Billion IDR | -41.73% |
| 2019 Q4 | 224.13 Billion IDR | 52.52% |
| 2019 Q3 | 146.95 Billion IDR | -13.87% |
| 2019 Q2 | 170.62 Billion IDR | 40.73% |
| 2019 FY | 662.95 Billion IDR | 7.5% |
| 2018 Q3 | 131.3 Billion IDR | -26.23% |
| 2018 FY | 616.69 Billion IDR | 15.86% |
| 2018 Q4 | 208.06 Billion IDR | 58.46% |
| 2018 Q2 | 177.99 Billion IDR | 79.2% |
| 2018 Q1 | 99.32 Billion IDR | -37.86% |
| 2017 Q2 | 121.01 Billion IDR | 17.63% |
| 2017 Q4 | 159.83 Billion IDR | 7.6% |
| 2017 FY | 532.26 Billion IDR | 7.38% |
| 2017 Q1 | 102.87 Billion IDR | -34.66% |
| 2017 Q3 | 148.53 Billion IDR | 22.74% |
| 2016 Q3 | 130.3 Billion IDR | 13.18% |
| 2016 Q4 | 157.44 Billion IDR | 20.83% |
| 2016 Q2 | 115.12 Billion IDR | 24.05% |
| 2016 FY | 495.69 Billion IDR | 22.53% |
| 2016 Q1 | 92.8 Billion IDR | -25.18% |
| 2015 Q1 | 56.2 Billion IDR | -62.79% |
| 2015 Q3 | 105.64 Billion IDR | -10.96% |
| 2015 Q2 | 118.65 Billion IDR | 111.11% |
| 2015 FY | 404.54 Billion IDR | 0.93% |
| 2015 Q4 | 124.03 Billion IDR | 17.41% |
| 2014 Q1 | 76.65 Billion IDR | -58.32% |
| 2014 Q3 | 100.26 Billion IDR | 37.67% |
| 2014 Q2 | 72.83 Billion IDR | -4.98% |
| 2014 Q4 | 151.04 Billion IDR | 50.64% |
| 2014 FY | 400.79 Billion IDR | -18.89% |
| 2013 Q4 | 183.88 Billion IDR | 78.67% |
| 2013 FY | 494.12 Billion IDR | 18.69% |
| 2013 Q2 | 127.67 Billion IDR | 60.28% |
| 2013 Q3 | 102.91 Billion IDR | -19.39% |
| 2013 Q1 | 79.65 Billion IDR | 0.0% |
| 2012 FY | 416.32 Billion IDR | -5.11% |
| 2011 FY | 438.74 Billion IDR | 24.98% |
| 2010 FY | 351.05 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 762.07 Billion IDR | -8.627% |
| PT Merck Tbk | 200.74 Billion IDR | -312.38% |
| PT Phapros, Tbk | 428.44 Billion IDR | -93.215% |
| PT Pyridam Farma Tbk | 293.43 Billion IDR | -182.114% |
| PT Tempo Scan Pacific Tbk | 3255.8 Billion IDR | 74.574% |